Genenta Science S.p.A. (Nasdaq: GNTA) in transformation to Saentra Forge (Nasdaq: SAEN), a strategic industrial consolidator focused on biotech, defense, aerospace, and national-security-related ...

Explore the captivating world of science fiction, blending humanity and science through thrilling narratives and imaginative subgenres.

Genenta Science S.p.A. (Nasdaq: GNTA) in transformation to Saentra Forge (Nasdaq: SAEN), a strategic industrial consolidator focused on biotech, defense, aerospace ...

Geneticist and entrepreneur Adrian Woolfson argues that genome engineering and AI will let us design organisms beyond nature’s limits ...

Market OutlookThe global in vitro toxicity testing market is expected to expand at a compound annual growth rate of around 10 ...

Bridging Nations. Accelerating Therapies for Rare Diseases Together. The organization’s 2030 vision institutionalizes ...

Harvard-trained Nigerian scientist, Dr. Olakunle Jaiyesimi, shares how leaving the country expanded his professional capacity ...

Gubra AS (STU:PI3) reports a robust financial performance with strategic expansions and investments, despite facing challenges in the US biotech market.

The matter pertains to a direction issued by the central government in November that will ensure app-based communication services, the likes of WhatsApp, Signal, Telegram, and others, are continuously ...

Chemical element in Belarus’ national security system The chemical industry plays a significant role in both our country’s and the ...

Several new guidance documents issued by the FDA are poised to significantly impact the rare disease development landscape.